Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pluristem Therapeutics Inc. PSTI

Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials, and manufacturing of cell therapeutics and related technologies.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Cultured meat proof of concept

Cultured meat proof of concept is right around the corner as the company said it will be published in Q2 at their investor call earlier this year.   rate and reply

New PSTI Company blog.

How can Pluristem’s technology help the environment? https://www.pluristem.com/pluristem-blog/how-can-pluristems-technology-help-the-environment/  rate and reply

Bull run alert!

Bull run alert!  Watch out, $PSTI is already up by 6% to start the day!  rate and reply

$PSTI vs S&P 500 YTD

$PSTI: -1% S&P 500: -17% $PSTI currently outperforming by 16%  rate and reply

$PSTI company blog- Pluristem’s Cell-Based Technology Platf

Key global challenges in sustainable development Humans are the most populous large animal on earth today.  In fact, the average global human population grows by 2.6 people every second (81...read more

Benzinga Interview with Pluristem President and CEO

An interesting look into $PSTI and their new collaboration strategy  https://www.youtube.com/watch?v=4bcHzVeRuTY&t=2s  rate and reply

$PSTI among the 5 Biotech Penny Stocks Redditors Love

Pluristem Therapeutics Inc. (NASDAQ:PSTI) is a biotech firm specializing in cell therapeutic products and related technologies. In early January, the stock jumped more than 30% after the company...read more

Cell and Gene Therapy Thawing Equipment Market report

Cell and Gene Therapy Thawing Equipment Market Research Report 2022 Cumulative Impact of COVID-19 Top companies in the market: Pluristem Therapeutics, Genesis BPS, Eppendorf, Cytiva (A subsidiary...read more

Cultured meat proof of concept in May?

The cultured meat proof of concept is expected to be published in Q2. Big chance it happens this month. The stock could really benefit and see and significant rise.    rate and reply

Pluristem therapeutics ($PSTI) stock analysis

https://www.youtube.com/watch?v=aiAVqrdQ4EI&t=136s  rate and reply

Israeli Companies Want to Bring Lab-grown Meat to the Masses

An Israeli biotech company and food giant Tnuva rang the bell at NASDAQ March 28, celebrating their partnership to produce lab-grown meat. Pluristem Therapeutics and Tnuva joined the race to create...read more

A New Cultured Meat report

A New Cultured Meat report was released by visualcapitalist.com.  The report, in part, talks about the big financial potential of this up-and-coming industry: "Depending on...read more

New Cultured Meat Report

A New Cultured Meat report was released by visualcapitalist.com.  The report, in part, talks about the big finincial potentcial of this upandconing industry: "Depending on factors such...read more

Yahoo Finance on $PSTI:

Pluristem Therapeutics Inc. (NASDAQ:PSTI) is an Israel-based biotechnology company that works to develop and research cell therapeutic products for the treatment of ischemic, inflammatory, and...read more

Cell and Gene Therapy to Witness Huge

Cell and Gene Therapy Thawing Equipment Market to Witness Huge Growth by 2029 | Pluristem Therapeutics Inc among the leaders in the market https://www.bloomingprairieonline.com/cell-and-gene-therapy...read more

Insider Monkey On $PSTI

 Pluristem Therapeutics Inc. (NASDAQ:PSTI) Number of Hedge Fund Holders: 4 Share Price as of April 5: $2.11 Pluristem Therapeutics Inc. (NASDAQ:PSTI) is an Israel-based biotechnology...read more

Cell Expansion Market To Reach Value Of USD 39.74 Billion

The global cell expansion market is estimated to reach value of USD 39.74 Billion by 2027, according to a current analysis by Emergen Research. Cell expansion is witnessing a surge...read more

PSTI could provide the first ever kosher meat product

PSTI could provide the first ever kosher meat product. The PSTI CEO said they have had discussions with rabbis and are expecting the product to be certified as kosher and pareve — that is, neither...read more

Pluristem and Tnuva Ring the Closing Bell Full Video

https://www.nasdaq.com/events/pluristem-and-tnuva-ring-the-closing-bell  rate and reply

Pluristem and Tnuva to Ring Nasdaq Closing Bell Today

Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI) (“Pluristem”), a leading biotechnology company, and Tnuva Group (“Tnuva Group” or “Tnuva”), Israel’s largest food producer, today announced...read more